GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (NYSE:BAX) » Definitions » Price-to-Operating-Cash-Flow

Baxter International (Baxter International) Price-to-Operating-Cash-Flow

: 11.64 (As of Today)
View and export this data going back to 1961. Start your Free Trial

As of today (2024-04-18), Baxter International's share price is $39.65. Baxter International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.41. Hence, Baxter International's Price-to-Operating-Cash-Flow Ratio for today is 11.64.

The historical rank and industry rank for Baxter International's Price-to-Operating-Cash-Flow or its related term are showing as below:

BAX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.19   Med: 17.47   Max: 27.61
Current: 11.57

During the past 13 years, Baxter International's highest Price-to-Operating-Cash-Flow Ratio was 27.61. The lowest was 6.19. And the median was 17.47.

BAX's Price-to-Operating-Cash-Flow is ranked better than
73.91% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 20.44 vs BAX: 11.57

Baxter International's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.41.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Baxter International was 41.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -5.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -4.20% per year.

During the past 13 years, Baxter International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 36.10% per year. The lowest was -25.10% per year. And the median was 5.70% per year.


Baxter International Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Baxter International's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.63 22.21 19.63 21.21 11.33

Baxter International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.21 13.87 14.79 11.71 11.33

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International Price-to-Operating-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Baxter International's Price-to-Operating-Cash-Flow falls into.



Baxter International Price-to-Operating-Cash-Flow Calculation

Baxter International's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=39.65/3.405
=11.64

Baxter International's Share Price of today is $39.65.
Baxter International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.41.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Baxter International Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Baxter International's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Baxter International (Baxter International) Business Description

Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
Executives
Joel T. Grade officer: EVP, Chief Financial Officer SYSCO CORPORATION, 1390 ENCLAVE PARKWAY, HOUSTON TX 77077
Stephen H Rusckowski director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Ampofo William A. Ii director ONE BAXTER PARKWAY, DEERFIELD IL 60015
Christopher A. Toth officer: EVP, Group Pres, Kidney Care 1252 COOLIDGE AVE., SAN JOSE CA 95125
Stroucken Albert P L director BAXTER INTERNATIONAL INC., ONE BAXTER PARKWAY, DEERFIELD IL 60015
Reaz Rasul officer: EVP, Group Pres, Healthcare ONE BAXTER PARKWAY, DEERFIELD IL 60015
Alok Sonig officer: EVP, Group President, Pharm ONE BAXTER PARKWAY, DEERFIELD IL 60015
Heather Knight officer: EVP, Group Pres, Medical ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jacqueline Kunzler officer: SVP, Chief Quality Officer ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jeanne K Mason officer: CVP, Human Resources ONE BAXTER PARKWAY, DEERFIELD IL 60015
Steven Flynn officer: SVP, President, APAC ONE BAXTER PARKWAY, DEERFIELD IL 60015
Peter M Wilver director
David Brent Shafer director 2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Amy Mcbride Wendell director COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Cathy R Smith director TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403